(Q37869402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Priscilla K Brastianos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

David A Palma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

1 reference

27 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

325-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-011-0594-5

29 January 2020

exact match

0 references

cites work

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Meta-analysis when only the median survival times are known: a comparison with individual patient data results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0594-5

Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases.

21 January 2018

1 reference

12 December 2020

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

12 December 2020

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

1 reference

12 December 2020

Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.

1 reference

12 December 2020

Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.

1 reference

12 December 2020

Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: what you don't see you can't get!

1 reference

12 December 2020

Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide

1 reference

12 December 2020

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

12 December 2020

A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis

1 reference

12 December 2020

Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.

1 reference

12 December 2020

10.1007/S11060-011-0594-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523485%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference